You are here: Industry Insights > COVID-19 vaccine

News List

China approves clinical trials for Livzon Pharma unit’s COVID-19 vaccine expresspharma
March 25, 2021
China’s medical products regulator has approved clinical trials for a COVID-19 vaccine candidate developed by a subsidiary of Livzon Pharmaceutical Group, the Chinese company said late on Tuesday.
NIAID statement on AstraZeneca vaccine and AstraZeneca update worldpharmanews
March 24, 2021
Late Monday, the Data and Safety Monitoring Board (DSMB) notified NIAID, BARDA, and AstraZeneca that it was concerned by information released by AstraZeneca on initial data from its COVID-19 vaccine clinical trial.
Initiative to Get COVID-19 Vaccines to People with Substance Use Disorder Launched by Addiction Policy Forum (APF) and Foundation for Opioid Response Efforts (FORE) prnewswire
March 24, 2021
In a major effort to get COVID-19 vaccines to one of the most vulnerable populations, the Foundation for Opioid Response Efforts (FORE) and the Addiction Policy Forum (APF) are launching a program to assist people with substance use disorder obtain ...
US health agency questions AstraZeneca’s Covid-19 vaccine trial data pharmaceutical-technology
March 24, 2021
US health officials have questioned the validity of AstraZeneca’s most recent vaccine trial results, saying the data provided by the company may be “outdated”.
Sinovac’s Covid-19 vaccine trial triggers immune responses in children pharmaceutical-technology
March 24, 2021
China-based company Sinovac Biotech has reported that preliminary results from Phase I and II clinical trials of its Covid-19 vaccine, CoronaVac, demonstrated it to be safe and could induce immune responses among children and adolescents.
Bhutan PM thanks Modi for gift of additional 4 00 000 doses of COVID-19 vaccine expresspharma
March 24, 2021
As part of the "Vaccine Maitri" initiative, India has supplied over 60 million doses of made-in-India COVID-19 vaccine to 72 nations.
New data boosts AstraZeneca COVID-19 vaccine in US expresspharma
March 23, 2021
The trials in the US, Chile and Peru showed the vaccine was 79 per cent effective at preventing symptomatic COVID-19.
South Africa sells COVID-19 vaccines procured from AstraZeneca to other AU member states expresspharma
March 23, 2021
The country had paused AstraZeneca vaccinations last month because of a small trial showing the shot offered minimal protection against mild to moderate illness caused by the dominant local coronavirus variant.
KM Biologics commences clinical trial of COVID-19 vaccine candidate expresspharma
March 23, 2021
The study is a combined Phase 1 and Phase 2 trial involving 210 subjects to test the vaccine’s safety and ability to trigger an immune response.
Interval between two doses of COVISHIELD increased to 4-8 weeks expresspharma
March 23, 2021
Protection enhanced if the second dose of COVISHIELD is administered between 6-8 weeks, says NTAGI and NEGVAC.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page